Skip to main content
AddLife logo

AddLife — Investor Relations & Filings

Ticker · ALIF ISIN · SE0014401378 LEI · 5493005T3M7CD7XWE013 ST Wholesale and retail trade
Filings indexed 294 across all filing types
Latest filing 2020-09-18 M&A Activity
Country SE Sweden
Listing ST ALIF

About AddLife

https://www.add.life/

AddLife is a life science group that operates through a decentralized model, acquiring and developing market-leading companies in niche segments. The group consists of numerous independent subsidiaries that provide specialized products, services, and advisory support primarily to the healthcare and research sectors. Its offerings encompass a broad range of instruments, equipment, consumables, and advanced solutions for diagnostics, medical technology, and biomedical research and laboratory analysis. AddLife's business strategy focuses on combining the strength and resources of a large enterprise with the entrepreneurial drive and agility of its subsidiaries, fostering growth and innovation while preserving the unique culture of each acquired company.

Recent filings

Filing Released Lang Actions
AddLife signs agreement with Italian SIAD Healthcare s.p.a. on the acquisition of advanced surgery business
M&A Activity Classification · 99% confidence The document explicitly announces an agreement for the acquisition of a business segment by AddLife from SIAD Healthcare. This involves a merger or takeover proposal, even if it's an asset acquisition structured as a business transfer. The key phrases are 'AddLife signs agreement... on the acquisition' and 'Possession is subject to a review and decision on foreign direct investments'. This directly aligns with the definition of M&A Activity (TAR), which covers merger proposals or takeover bids.
2020-09-18 English
AddLife tecknar avtal med italienska SIAD Healthcare s.p.a. om förvärv av verksamhet inom avancerad kirurgi
M&A Activity Classification · 99% confidence The document text is a press release announcing that AddLife has signed an agreement to acquire the advanced surgery business from SIAD Healthcare s.p.a. This is a corporate action related to mergers and acquisitions (M&A). Based on the definitions, the most appropriate category for an announcement regarding a merger proposal or takeover bid is 'M&A Activity' (Code: TAR). The document details the transaction, involved parties, expected impact, and closing conditions, confirming it is a specific M&A announcement, not a general regulatory filing (RNS) or a report itself.
2020-09-18 Swedish
Ändrat datum för offentliggörande av Delårsrapport 1 januari – 30 september 2020
Report Publication Announcement Classification · 99% confidence The document text is very short (1248 characters) and its primary purpose is to announce a change in the publication date for an upcoming financial report ('Delårsrapporten 1 januari – 30 september 2020'). It states the new release time and date. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement regarding the timing or publication of a report, rather than the report itself, should be classified as a Report Publication Announcement (RPA). The document explicitly announces when the Interim Report (IR) will be released.
2020-09-08 Swedish
Changed date for the publishing of the Interim Report 1 January – 30 September 2020
Report Publication Announcement Classification · 99% confidence The document explicitly states that the board of directors has decided to reschedule the publishing date of the 'Interim Report for 1 January – 30 September 2020'. The text itself is a short announcement about the timing of a future report release, not the report content itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The document length (1282 chars) also supports the 'MENU VS MEAL' rule, indicating an announcement rather than the full report.
2020-09-08 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for AddLife covering the period 1 January to 30 June 2020. It contains comprehensive financial statements, including income statements, cash flow data, and management commentary (VD-kommentar) regarding the company's performance during the COVID-19 pandemic. Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2020
2020-07-17 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 1 January – 30 June 2020' and contains comprehensive financial statements, including net sales, EBITA, profit after tax, and earnings per share for both the 3-month and 6-month periods. It includes detailed management commentary, business area analysis (Labtech), and comparative financial tables. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-07-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.